1. Home
  2. IMMX vs SND Comparison

IMMX vs SND Comparison

Compare IMMX & SND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IMMX
  • SND
  • Stock Information
  • Founded
  • IMMX 2014
  • SND 2011
  • Country
  • IMMX United States
  • SND United States
  • Employees
  • IMMX N/A
  • SND N/A
  • Industry
  • IMMX Medicinal Chemicals and Botanical Products
  • SND Mining & Quarrying of Nonmetallic Minerals (No Fuels)
  • Sector
  • IMMX Health Care
  • SND Industrials
  • Exchange
  • IMMX Nasdaq
  • SND Nasdaq
  • Market Cap
  • IMMX 65.5M
  • SND 75.7M
  • IPO Year
  • IMMX 2021
  • SND 2016
  • Fundamental
  • Price
  • IMMX $2.00
  • SND $1.98
  • Analyst Decision
  • IMMX Strong Buy
  • SND
  • Analyst Count
  • IMMX 1
  • SND 0
  • Target Price
  • IMMX $8.00
  • SND N/A
  • AVG Volume (30 Days)
  • IMMX 183.0K
  • SND 84.0K
  • Earning Date
  • IMMX 11-11-2025
  • SND 11-11-2025
  • Dividend Yield
  • IMMX N/A
  • SND 5.08%
  • EPS Growth
  • IMMX N/A
  • SND N/A
  • EPS
  • IMMX N/A
  • SND 0.02
  • Revenue
  • IMMX N/A
  • SND $305,848,000.00
  • Revenue This Year
  • IMMX N/A
  • SND N/A
  • Revenue Next Year
  • IMMX N/A
  • SND N/A
  • P/E Ratio
  • IMMX N/A
  • SND $91.56
  • Revenue Growth
  • IMMX N/A
  • SND 3.43
  • 52 Week Low
  • IMMX $1.26
  • SND $1.76
  • 52 Week High
  • IMMX $3.20
  • SND $2.80
  • Technical
  • Relative Strength Index (RSI)
  • IMMX 48.92
  • SND 52.29
  • Support Level
  • IMMX N/A
  • SND N/A
  • Resistance Level
  • IMMX $2.34
  • SND $1.93
  • Average True Range (ATR)
  • IMMX 0.15
  • SND 0.05
  • MACD
  • IMMX -0.08
  • SND -0.07
  • Stochastic Oscillator
  • IMMX 85.11
  • SND 99.25

About IMMX Immix Biopharma Inc.

Immix Biopharma Inc is engaged in the discovery and development of novel cell therapies for hematologic malignancies (blood cancers) and other indications. It is a clinical-stage biopharmaceutical company developing a novel class of Tissue-Specific Therapeutics TM in oncology and inflammation. Its TME Normalization Technology allows drug candidates to circulate in the bloodstream, exit through tumor blood vessels and simultaneously attack all components of the TME. Its product candidates include CAR-T NXC-201 for autoimmune diseases, and IMX-110 for treatment of soft tissue sarcoma.

About SND Smart Sand Inc.

Smart Sand Inc. is a fully integrated frac sand company providing mine-to-well site proppant supply and logistics. It produces Northern White frac sand for enhanced hydrocarbon recovery in oil and gas wells. The company offers products like Smart System, SmartBelt, SmartDepot Silo, and SmartPath Loader. It is expanding into industrial markets, including glass, ceramics, and renewable energy, while its main revenue comes from sand sales and logistics.

Share on Social Networks: